Acute Management of Uncontrolled Diabetes with Repeated Vomiting
Begin immediate fluid resuscitation with isotonic saline at 15–20 mL/kg/hour while simultaneously assessing for diabetic ketoacidosis through point-of-care glucose, venous pH, and serum ketones. 1, 2, 3
Immediate Assessment (First 15–30 Minutes)
Laboratory workup:
- Obtain venous blood gas (pH, bicarbonate), serum glucose, electrolytes with calculated anion gap, blood β-hydroxybutyrate (preferred over urine ketones), BUN, creatinine, and serum osmolality 1, 2, 3
- Check serum potassium before starting any insulin—this is an absolute requirement 1, 2, 3
- Obtain ECG, complete blood count, urinalysis, and bacterial cultures (blood, urine, throat) if infection is suspected 1, 3
DKA diagnostic criteria (all must be present):
- Glucose >250 mg/dL 2, 3
- Venous pH <7.3 2, 3
- Serum bicarbonate <15 mEq/L 2, 3
- Moderate-to-large ketonemia (β-hydroxybutyrate preferred) 2, 3
- Anion gap >12 mEq/L 2, 3
Fluid Resuscitation Protocol
First hour:
- Administer 0.9% NaCl at 15–20 mL/kg/hour (approximately 1–1.5 L in average adult) to restore intravascular volume and improve insulin sensitivity 1, 2, 3
- This aggressive initial fluid replacement is critical and takes priority over insulin 4, 3
After first hour:
- Calculate corrected sodium: add 1.6 mEq/L for each 100 mg/dL glucose above 100 mg/dL 1, 2, 3
- If corrected sodium is normal or elevated: switch to 0.45% NaCl at 4–14 mL/kg/hour 1, 2, 3
- If corrected sodium is low: continue 0.9% NaCl at 4–14 mL/kg/hour 1, 2, 3
When glucose falls to 250 mg/dL:
- Change IV fluid to 5% dextrose with 0.45–0.75% NaCl while continuing insulin infusion 1, 2, 3
- Never stop insulin when glucose normalizes—ketone clearance lags behind glucose correction 1, 2, 3
Potassium Management (Class A Evidence)
This is the most critical safety step—insulin-induced hypokalemia is a leading cause of DKA mortality. 1, 2, 3
If K⁺ <3.3 mEq/L:
- Do NOT start insulin under any circumstances 1, 2, 3
- Aggressively replace potassium at 20–40 mEq/hour until K⁺ ≥3.3 mEq/L 1, 2
- Obtain ECG to assess for cardiac effects of hypokalemia 1
- This threshold is an absolute contraindication with Class A evidence 1, 2
If K⁺ 3.3–5.5 mEq/L:
- Insulin may be started safely 1, 2, 3
- Add 20–30 mEq/L potassium to each liter of IV fluid (use 2/3 KCl and 1/3 KPO₄) once urine output is adequate 1, 2, 3
- Target serum potassium 4.0–5.0 mEq/L throughout treatment 1, 2
If K⁺ >5.5 mEq/L:
- Start insulin immediately without potassium supplementation 1, 2
- Monitor potassium every 2–4 hours as levels will drop rapidly 1, 2
- Add potassium once level falls below 5.5 mEq/L 1, 2
Insulin Therapy
For moderate-to-severe DKA or altered mental status:
- Give IV bolus of 0.1 units/kg regular insulin 1, 2, 3
- Start continuous infusion at 0.1 units/kg/hour (approximately 5–7 units/hour in adults) 1, 2, 3
- Target glucose decline of 50–75 mg/dL per hour 1, 2
If glucose does not fall by ≥50 mg/dL in first hour:
- Verify adequate hydration status 1, 2, 3
- Double insulin infusion rate every hour until steady decline achieved 1, 2, 3
Alternative for mild-moderate uncomplicated DKA:
- For hemodynamically stable, alert patients: subcutaneous rapid-acting insulin analogs (0.1–0.2 units/kg every 1–2 hours) combined with aggressive IV fluids may be equally effective and more cost-effective 1, 3
- This requires frequent glucose monitoring and appropriate follow-up 1, 3
Anti-Emetic Management
Administer anti-emetic medication promptly to facilitate early resumption of oral carbohydrate intake, as adults require 150–200 g carbohydrate daily to suppress ketogenesis 2
Once nausea resolves:
- Provide liquid carbohydrate sources (juice, broth, sports drinks) in small frequent portions 2
- Aim for 45–50 g carbohydrate every 3–4 hours 2
- Insulin alone cannot clear ketones without adequate carbohydrate substrate 2
Monitoring Protocol
Every 2–4 hours until stable:
- Blood glucose 1, 2, 3
- Serum electrolytes (especially potassium) 1, 2, 3
- Venous pH (0.03 units lower than arterial—arterial gases not required after initial diagnosis) 1, 2
- Serum bicarbonate and anion gap 1, 2, 3
- BUN, creatinine, serum osmolality 1, 2, 3
Use blood β-hydroxybutyrate for ketone monitoring:
- Direct β-hydroxybutyrate measurement is the gold standard 1, 2, 3
- Never rely on urine ketones or nitroprusside tests—they miss the predominant ketone body and can be misleading during treatment 1, 2, 3
DKA Resolution Criteria (All Must Be Met)
- Glucose <200 mg/dL 1, 2, 3
- Serum bicarbonate ≥18 mEq/L 1, 2, 3
- Venous pH >7.3 1, 2, 3
- Anion gap ≤12 mEq/L 1, 2, 3
Transition to Subcutaneous Insulin
Administer long-acting basal insulin (glargine or detemir) 2–4 hours BEFORE stopping IV insulin infusion to prevent rebound hyperglycemia and recurrent DKA 1, 2, 3
Continue IV insulin for 1–2 hours after subcutaneous basal dose to ensure adequate absorption 1, 2
Dosing strategy:
- Use approximately 50% of total 24-hour IV insulin amount as single daily basal dose 1
- Divide remaining 50% equally among three meals as rapid-acting insulin 1
Critical Pitfalls to Avoid
Never start insulin if potassium <3.3 mEq/L—this can precipitate fatal cardiac arrhythmias (Class A evidence) 1, 2, 3
Never stop IV insulin without 2–4 hour basal insulin overlap—this is the most common cause of recurrent DKA 1, 2, 3
Never hold insulin when glucose falls to 250 mg/dL—instead add dextrose to IV fluids while maintaining insulin infusion to clear ketones 1, 2, 3
Never rely solely on urine ketones—they lag behind serum β-hydroxybutyrate clearance and do not measure the predominant ketone body 1, 2, 3
Avoid bicarbonate therapy unless pH <6.9—multiple studies show no benefit and potential harms (worsened ketosis, hypokalemia, increased cerebral edema risk) 1, 3
Identify and Treat Precipitating Cause
Common triggers requiring concurrent treatment: